Skip to main content
PEN
NYSE Life Sciences

Penumbra Q2 Revenue Edges Past Estimates, Net Income Drops on Deal Costs

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$319.83
Mkt Cap
$12.579B
52W Low
$221.26
52W High
$362.41
52W Position info
45% above low
Off High info
12% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

PEN sits 45% above its 52-week low of $221.26.

Summary

Penumbra's Q2 revenue rose 14.9% to $390.05M, just above the $389M consensus, driven by 20% growth in embolization and access products. Net income fell to $34.8M from $45.3M a year ago, weighed down by $6.9M in acquisition-related expenses tied to the pending Boston Scientific deal. The company is not providing full-year guidance, citing the acquisition. This follows the May 7 stockholder approval of the merger, keeping the $14.5B deal on track. With the stock trading at 56x forward earnings and a hold-heavy analyst consensus, the slight revenue beat is unlikely to shift sentiment dramatically, but the deal costs and lack of guidance reinforce a wait-and-see stance.

At the time of this announcement, PEN was trading at $319.83 on NYSE in the Life Sciences sector, with a market capitalization of approximately $12.6B. The 52-week trading range was $221.26 to $362.41. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PEN - Latest Insights

PEN
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $321.99
Real-time Price: $320.50 info
Change: -$1.49 (-0.46%) info
Market Cap: $12.613B info
PEN
Oct 29, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $321.97
Real-time Price: $320.50 info
Change: -$1.47 (-0.46%) info
Market Cap: $12.613B info
PEN
Oct 20, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $321.73
Real-time Price: $320.50 info
Change: -$1.23 (-0.38%) info
Market Cap: $12.613B info
PEN
Jul 30, 2026, 4:44 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $320.50 info
Change: +$0.670 (+0.21%) info
Market Cap: $12.613B info
PEN
Jul 30, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $319.83
Real-time Price: $320.50 info
Change: +$0.670 (+0.21%) info
Market Cap: $12.613B info